highly significantP < 0.0001
Similarly, by week 36, a highly significant reduction of 37.3% was found in the Resmetirom group compared with a decrease of 8.5% in the placebo group ( P < 0.0001).
Similarly, by week 36, a highly significant reduction of 37.3% was found in the Resmetirom group compared with a decrease of 8.5% in the placebo group ( P < 0.0001).